FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Phosphates Injection
Status: Currently in Shortage
»Date first posted: 09/01/2021
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (New 09/01/2021)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Phosphorus 15 mmol/5 mL, Sodium 20 mEq/5 mL, vial (NDC 63323-170-05) Backordered. Next release October 2021. Manufacturing delay. Check wholesaler for inventory. Other
Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 63323-170-15) Backordered. Next release October 2021. Manufacturing delay. Check wholesaler for inventory. Other

Hospira, Inc. (Revised 09/09/2021)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL, vial (NDC 0409-7391-72) Next Delivery: November 2021; Estimated Recovery: January 2022 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English